US2021122978A1PendingUtilityA1
Liquid Crystals Comprising Cyclopentane Groups
Est. expiryFeb 8, 2028(~1.5 yrs left)· nominal 20-yr term from priority
C09K 19/30C09K 19/3405C07C 25/22C07C 2601/08C09K 2019/3408C09K 2323/00C09K 19/322
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are liquid crystal compounds and mixtures incorporating the same. The liquid crystal compounds of the invention generally comprise a cyclopentane group and at least two other rings. In one embodiment, the liquid crystal compounds of the invention comprise a cyclopentane group and at least two other rings, one of which is a fused ring system.
Claims
exact text as granted — not AI-modified1 .- 19 . (canceled)
20 . A compound having the formula:
wherein:
R is selected from the group consisting of H and unsubstituted or substituted alkyl each having I-12 carbon atoms, wherein the substitutions are independently one or more of halogen or CN, and wherein one or more CH 2 groups of the alkyl groups are optionally independently replaced with —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— or —CH═CH—, provided that heteroatoms are not connected directly, except as permitted in the listed groups;
A and B rings are each independently selected from the group consisting of: 1,4-cyclohexyl, in which one CH 2 or two not directly linked CH 2 are optionally replaced by O or S; 1,4-cyclohexenyl; piperidine-1,4-diyl; 1,4-bicyclo[2,2,2]octylene; 1,4-phenyl, which is optionally substituted with one or more halogens; pyridin-5,2-dyl; pyrimidin-5,2-diyl; naphthalene-2,6-diyl; trans-decahydronaphthalene-2,6-diyl; tetrahydronaphthalene-2,6-diyl; indane; indene; phenanthryl; and dibenzofuran, which each independently in each instance are optionally independently substituted with one or more halogens and/or one or more X 1 -X 4 substituents;
Z 1 is a single bond or CI-7 unsubstituted or substituted alkylene, wherein the substitutions are independently one or more of halogen or CN, wherein one or more CH 2 group of the alkylene are independently optionally replaced by —O—, —S—, —CO—O—, —O—CO—, —O—CO—O— or —CH═CH—, provided that heteroatoms are not connected directly to each other except as permitted in the listed groups;
Z 2 and Z 3 are each independently selected from the group consisting of: a single bond, —(CH 2 ) 2 —, —(CH 2 ) 4 —, —CH═CHCH 2 CH 2 —, —CH 2 CH 2 CH═CH—, —CF 2 O—, —OCF 2 —, —CF 2 CF 2 —, —CF═CF—, —CH 2 CF 2 , —CF 2 CH 2 —, —OCF 2 CF 2 O—, —C 2 H 4 CF 2 O—, —CH 2 CF 2 OCH 2 —, —CH 2 OCF 2 CH 2 —, —OCF 2 C 2 H 4 —, —C 3 H 6 O—, —OC 3 H 6 —, —C 2 H 4 OCH 2 —, —CH 2 OC 2 H 4 —, —CH 2 O—, —OCH 2 —, —CH═CH—, —C≡C—, and —COO—;
n, m and K are each independently 0, 1, or 2, and m+K+n≥2;
X 1 , X 2 , X 3 , and X 4 are each independently selected from the group consisting of: H, F, Cl, CF 3 , CHF 2 , OCF 3 or OCF 2 H and CN;
Y is independently selected from the group consisting of: H, F, Cl, CN, NCS, OCHF 2 , CHF 2 , OCF 3 , OCF 2 CF 3 , CF 3 , C 1-20 alkyl, C 1-20 alkoxy, C 1-20 alkenyl, and C 1-20 alkenyloxy, wherein the alkyl, alkoxy, alkenyl, and alkenyloxy groups independently are optionally substituted by one or more halogens;
wherein one or more hydrogen atoms in Formula I are optionally replaced with deuterium;
provided that:
(1) when R═H and Y has less than 2 carbon atoms and both X 3 and X 4 are H or when R═H and Y has two or more carbon atoms and Z 1 has more than 3 carbon atoms,
then:
there is a fused ring system in the compound or
one of Z 1 , Z 2 and Z 3 is selected from the group consisting of: C1-C3 alkylene, —CH═CHCH 2 CH 2 —, —CH 2 CH 2 CH═CH—, —CF 2 O—, —OCF 2 —, —CF 2 CF 2 —, —CF═CF—, —CH 2 CF 2 , —CF 2 CH 2 —, —OCF 2 CF 2 O—, —C 2 H 4 CF 2 O—, —CH 2 CF 2 OCH 2 —, —CH 2 OCF 2 CH 2 —, —OCF 2 C 2 H 4 —, —C 3 H 6 O—, —OC 3 H 6 —, —C 2 H 4 OCH 2 —, —CH 2 OC 2 H 4 —, and —CH═CH—; and
(2) when R is not H and Y does not contain a —CF2- group,
then:
either one of the A or B ring is selected from the group consisting of: 1,4-cyclohexene, in which one or two not directly linked CH 2 groups are optionally replaced by O or S; pyridin-5,2-dyl; pyrimidin-5,2-diyl; indane; indene; phenanthryl, or dibenzofuran; or
one of Z 1 , Z 2 and Z 3 is selected from the group consisting of: —(CH 2 ) 4 —, —CH═CHCH 2 CH 2 —, —CH 2 CH 2 CH═CH—, —CF 2 O—, —OCF 2 —, —CF 2 CF 2 —, —CF═CF—, —CH 2 CF 2 , —CF 2 CH 2 —, —OCF 2 CF 2 O—, —C 2 H 4 CF 2 O—, —CH 2 CF 2 OCH 2 —, —CH 2 OCF 2 CH 2 —, —OCF 2 C 2 H 4 —, —C 3 H 6 O—, —OC 3 H 6 —, —C 2 H 4 OCH 2 —, —CH 2 OC 2 H 4 —, —CH═CH—, and —C≡C—.
21 . The compound of claim 20 , wherein Y is H.
22 . The compound of claim 20 , wherein K is 0.
23 . The compound of claim 20 , wherein m+K+n is 2.
24 . The compound of claim 20 , wherein m+K+n is 3.
25 . The compound of claim 20 having a negative dielectric constant.
26 . The compound of claim 20 , having any one of formulas I-18 through I-47:
and wherein one, two three, four, five or six of X 1 -X 6 , are F and the others of X 1 -X 6 are H.
27 . A compound of claim 26 , wherein R′ is H.
28 . A compound of claim 27 having formula:
29 . A compound of claim 26 having formula I-22 to I-27, I-29-I33 or I-38-1-40.
30 . A liquid crystal mixture having comprising a compound of claim 20 and having a negative dielectric constant.
31 . The mixture of claim 30 , wherein the mixture further comprises at least one compound of formula XXIV-XLIV as shown herein.
32 . The mixture of claim 30 , wherein the mixture further comprises at least one compound of formula XLV-XLVIII as shown herein.
33 . The mixture of claim 30 , wherein the mixture comprises at least one compound of formula XXIV-XLIV as shown herein and at least one compound of formula XLV-XLVIII as shown herein.
34 . A device comprising a compound of claim 20 .
35 . A device comprising a mixture of claim 30 .Join the waitlist — get patent alerts
Track US2021122978A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.